Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Harbor

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Harbor a 75. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Harbor

#128 · Grade C+ · Fair Price

Est. first month

From $99/mo (starting dose, compounded)

Save ~93% vs brand-name
Get this deal Full Harbor review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 75 an est. $99/mo first month, with no teaser step-up baked in. Harbor isn't out of it: Shoppers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDHarbor
Value Score89 (A)75 (C+)
Est. first month$99/moFrom $99/mo (starting dose, compounded)
Save vs brand-name~93%~93%
Semaglutide$99/moFrom $99/mo (starting dose, compounded)
Tirzepatide$139/moFrom $149/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
90
bmiMD: 95. Harbor: 90.
84
No Teaser-Rate Bait
64
bmiMD: 84. Harbor: 64.
98
Nationwide Availability
45
bmiMD: 98. Harbor: 45.
94
Both Molecules
92
bmiMD: 94. Harbor: 92.
82
Easy Cancellation
58
bmiMD: 82. Harbor: 58.
70
Reputation
78
bmiMD: 70. Harbor: 78.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Harbor

Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Why it's a deal

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

The fine print

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
Get the bmiMD deal Get the Harbor deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Harbor.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.